Teva Pharmaceutical Industries Ltd (TEVJF) — 8-K Filings

8-K Filings (16)

• 8-K Filing — Dec 11, 2025
• 8-K Filing — Nov 5, 2025
• Teva Pharma Files 8-K on Operations & Financials — Jul 30, 2025 Risk: low
  Teva Pharmaceutical Industries Ltd. filed an 8-K on July 30, 2025, reporting on its results of operations and financial condition. The filing includes financial
• Teva Pharmaceuticals Files 8-K on Security Holder Vote Matters — Jun 5, 2025 Risk: low
  On June 5, 2025, TEVA PHARMACEUTICAL INDUSTRIES LTD filed an 8-K report indicating a submission of matters to a vote of security holders. The filing details are
• Teva Pharmaceuticals Files 8-K on Material Agreement — May 28, 2025 Risk: medium
  On May 28, 2025, TEVA PHARMACEUTICAL INDUSTRIES LTD filed an 8-K report detailing a material definitive agreement and the creation of a direct financial obligat
• Teva Pharma Files 8-K — May 22, 2025 Risk: low
  Teva Pharmaceutical Industries Ltd. filed an 8-K on May 22, 2025, reporting events as of May 20, 2025. The filing indicates disclosures related to Regulation FD
• Teva Pharma Files 8-K on Operations and Financials — May 7, 2025 Risk: low
  Teva Pharmaceutical Industries Ltd. filed an 8-K on May 7, 2025, reporting on its Results of Operations and Financial Condition, and submitting Financial Statem
• Teva Pharmaceuticals Files 8-K on Financials — Jan 29, 2025 Risk: low
  On January 29, 2025, TEVA PHARMACEUTICAL INDUSTRIES LTD filed an 8-K report. The filing pertains to the company's results of operations and financial condition,
• Teva Pharma Announces Executive and Director Changes — Nov 12, 2024 Risk: medium
  Teva Pharmaceutical Industries Ltd. announced on November 5, 2024, changes in its executive team. The company elected new directors and appointed certain office
• Teva Pharma Files 8-K on Operations & Financials — Nov 6, 2024 Risk: low
  Teva Pharmaceutical Industries Ltd. filed an 8-K on November 6, 2024, reporting on its results of operations and financial condition, and also including financi
• Teva Pharma Files 8-K on Operations and Financials — Jul 31, 2024 Risk: low
  On July 31, 2024, Teva Pharmaceutical Industries Ltd. filed an 8-K report to disclose information regarding its results of operations and financial condition, a
• Teva Pharma Signs Material Definitive Agreement — Jun 25, 2024 Risk: medium
  Teva Pharmaceutical Industries Ltd. entered into a material definitive agreement on June 23, 2024. The filing does not disclose specific details of the agreemen
• Teva Pharmaceuticals Files 8-K on Security Holder Vote — Jun 6, 2024 Risk: low
  On June 6, 2024, TEVA PHARMACEUTICAL INDUSTRIES LTD filed an 8-K report indicating a submission of matters to a vote of security holders. The filing does not co
• Teva Pharma Appoints New CFO, Elects Directors — May 15, 2024 Risk: medium
  Teva Pharmaceutical Industries Ltd. announced on May 15, 2024, changes in its executive team. The company elected two new directors, Dr. Ghiath Sharbain and Ms.
• Teva Pharma Files 8-K with 2023 Segment Financials — Apr 18, 2024 Risk: low
  Teva Pharmaceutical Industries Ltd. filed an 8-K on April 18, 2024, to report financial statements and exhibits. The filing includes segment information for the
• TEVA Files 8-K on Operations & Financial Condition — Jan 31, 2024
  TEVA PHARMACEUTICAL INDUSTRIES LTD filed an 8-K on January 31, 2024, to report on its 'Results of Operations and Financial Condition' and 'Financial Statements

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX